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ScienceDirectThe Male Specific Lethal (MSL) complex provides an exquisite
example of an epigenetic modulator that is involved in
chromosome-wide as well as individual gene regulation in flies
and mammals. In this review, we discuss the recent advances
in biochemical and structural understanding of the MSL
complex modules and how they function in X chromosome
regulation in flies. Moreover, we describe possible conserved
and dosage compensation-independent functions of the MSL
complex with a particular focus on mammalian systems.
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Introduction
Sex determination mechanisms in different organisms are
extraordinarily diverse and in many instances involve
chromosomal differences between the two sexes. In Cae-
norhabditis elegans, Drosophila and mammals, males are
heterogametic (XY), whereas females are homogametic
(XX) [1]. Interestingly, parallel mechanisms operating on
a chromosome-wide level have evolved to ensure equal
gene expression from sex chromosomes. Already three
decades ago, Male-Specific Lethal (MSL) mutants have
been identified and characterized in the fruit fly Drosoph-
ila melanogaster, leading to the notion that in flies, dosage
compensation manifests in males [2,3]. Since then, dos-
age compensation has become a paradigm to study chro-
mosome-wide transcription regulation by epigenetic
mechanisms.
Biochemically, at least five proteins, MSL1, MSL2,
MSL3, MOF (males-absent-on-the first) and MLE (male-
less) as well as two non-coding RNAs roX1 and/or roX2
(RNA on the X) form a complex known as the MSLwww.sciencedirect.com complex [4,5,6,7,8]. The MSL complex assembles ex-
clusively in male flies, as translation of the msl-2 mRNA is
inhibited in females by the RNA binding protein sex-
lethal (sxl) [9,10]. It mediates global acetylation of histone
H4 lysine 16 (H4K16ac) on the single male X chromo-
somes, which causes an upregulation of transcription
[11,12,13,14,15,16].
Notably, apart from MSL2, other MSL complex members
are also expressed in female flies and orthologs exist in
many species, where dosage compensation mechanisms
are absent or fundamentally different. This suggests that
the MSL complex members also function outside of the
dosage compensation machinery, a property that is likely
to be mediated by the different enzymatic and protein-
interaction modules found in these proteins. For example,
MOF additionally resides in the Non-Specific Lethal
complex (NSL complex), which is involved in global
transcription regulation of housekeeping genes in both
sexes [17,18]. Here, we review MSL complex function in
dosage compensation in flies with a particular focus on
recent structural and biochemical work. On the basis of
this, we discuss possible conserved, dosage compensation-
independent, functions focussing on mammalian systems.
Structural analyses of MSL2 revealed the
targeting principles of the MSL complex
The MSL complex orchestrates dosage compensation on
the male X chromosome in a multistep process (Figure 1).
Firstly, the complex is targeted to numerous high-affinity
sites (HAS) on the X, following its complete assembly
[19,20,21]. Then, it spreads from HAS to the rest of the X
establishing chromosome-wide H4K16ac. This results in
upregulated transcription on the X chromosome, which is
stably maintained and requires tight control of MSL
complex levels. To accomplish these complex events,
the core MSL complex contains several enzymatic and
multiple adaptor modules.
The fact that MSL2 expression is inhibited in females,
underscores that MSL2 is probably the most central
regulator of dosage compensation [7]. The MSL2 protein
functions in targeting of HAS on the X chromosome
(Figure 1a), MSL complex assembly (Figure 1b) and
control of functional MSL complex levels (Figure 1d).
HAS targeting is probably mediated by the MSL2 CXC
domain and might involve nucleic acid binding [22]
(Figure 2). It occurs before full MSL complex assembly,
as in the absence of MOF, a partial MSL complexCurrent Opinion in Genetics & Development 2015, 31:1–11
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Stepwise establishment of dosage compensation in Drosophila via the MSL complex. (a) Targeting: MSL2 (blue) via its CXC domain recognizes
high affinity sites (HAS) (red) on the male X-chromosome. Nucleosomes are visualized in grey. (b) Assembly: Dimerization of MSL1 (black/grey)
provides an interaction surface for the MSL2 RING domain and is a first important step in complex assembly. It is possible that before the
interaction with MSL2, MSL1 is preassembled with MOF (red/orange) and MSL3 (green) in a trimer or hexamer, already. Alternatively, MOF
association occurs in a second step after MSL1/MSL2 interaction. Because in ChIP experiments, MSL3 association with HAS is minimal, it is
also possible that MSL3 incorporation occurs later. Lastly, rox1/2 ncRNA (red) integration is catalysed by the RNA helicase MLE (pink). MLE
can only be found at high affinity sites by ChIP and its association with the complex is transient. Possibly, these events lead to conformational
changes rendering the complex in a spreading competent form (c). (c) Spreading: Once the complex is fully assembled, the complex is thought
to spread from HAS to actively transcribed regions in a chromosome-wide manner. The exact mechanism of transition from assembly at HAS to
spreading is unknown; however, MSL3 seems to have a key role in this process. Ultimately, this leads to H4K16 hyperacetylation of the entire
Current Opinion in Genetics & Development 2015, 31:1–11 www.sciencedirect.com
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Figure 2
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Overview of the domain architecture and functions of the Drosophila and human MSL complex proteins. The core MSL complex members MSL1,
2, 3 and MOF have distinct domains, which each are responsible for different functions. Percent similarity to the human proteins was calculated
using the CLUSTALO program. The domain architecture of the complex members is remarkably similar between Drosophila and mammals,
however note, that most of the mammalian proteins are considerably smaller. The PEHE and CXC domains are named after the amino acids,
which are characteristic for these domains: proline (P), glutamate (E), histidine (H), glutamate (E) for PEHE and cysteines (C) intervened by any
amino acid (X) for CXC [86]. CC: coiled-coil, RING: really interesting new gene, CD: chromodomain, MRG: morf-related gene, CB: chromobarrel
domain, HAT: histone acetyltransferase, RB: double-stranded RNA binding domain, G: glycine-rich C-terminus.consisting of MSL2, MLE and to some degree MSL1
resides at HAS [23]. Furthermore, it is possible that MSL
complex targeting by MSL2 is aided by the presence of
other co-factors [24,25]. Interestingly, on the one side
targeting appears to be dynamic, as inhibition of tran-
scription leads to loss of the MSL complex members on
the X chromosome [26]. On the other hand, a FRAP
(fluorescence recovery after photobleaching) study
revealed remarkably stable MSL2 association with the
X chromosome [27]. Therefore, a combination of dynamic(Figure 1 Legend Continued) male X. (d) Homeostasis: Homeostasis of fu
ubiquitination and degradation of MSL2 and MSL1. As MSL1 forms the int
complex disassembly. Most probably, homeostasis is required to prevent 
complex association with autosomes.
www.sciencedirect.com and stable interactions helps in establishing dosage com-
pensation.
MSL complex assembly and control of its protein levels is
mediated by the MSL2 RING domain (Figure 1). Over-
expression of MSL2 results in inappropriate MSL com-
plex binding to autosomes [28]. By contrast, depletion
results in destabilization of MSL3 and MLE and thereby
disintegration of the MSL complex [29]. MSL2 also
negatively controls MSL1 levels, as MSL1 mutants thatnctional MSL levels on chromatin occurs via MSL2-mediated
egral scaffold of the complex, degradation of MSL1 will lead to
accumulation of MSL complexes, which might lead to unwanted MSL
Current Opinion in Genetics & Development 2015, 31:1–11
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Comparison of the architecture and function of the Drosophila and mammalian MSL complexes. (a) The core Drosophila and mammalian MSL
complexes adopt the same overall architecture consisting of a MSL1 dimer, which is bridging interactions with MSL2 at its N-terminus, as well as
MOF and MSL3 at its C-terminus. Note, however, that the unstructured region between the MSL1 N-terminus and C-terminus is smaller in
mammals, resulting in reduced complex size. The RNA helicase MLE and the ncRNAs roX1/2 are important functional components of the
Drosophila MSL complex. Whether an RNA component is part of the mammalian MSL complex is not known. (b) Schematic chromatin binding
profiles of the MSL complex and H4K16ac on the male X chromosome. Association with promoters (black box with arrow), gene bodies (grey) and
Current Opinion in Genetics & Development 2015, 31:1–11 www.sciencedirect.com
Dosage compensation in Drosophila Keller and Akhtar 5fail to interact with MSL2 can be expressed to much
higher levels than the wild-type MSL1, in vivo. Further-
more, interaction of MSL1 with MSL2 is essential for
dosage compensation [30].
Recent biochemical and structural studies revealed the
molecular basis for this, showing that the MSL2 RING
domain acts both as an enzyme as well as a protein–protein
interaction module [30,31]. Two MSL2 alpha helices in-
teract with an MSL1 dimer formed through an N-terminal
coiled-coiled region in a 2:2 stoichiometry. These findings
were unexpected and showed, that the core MSL complex
is most probably an octamer consisting of two molecules
of each MSL1, MSL2, MSL3 and MOF (Figure 3a).
The MSL2 RING finger itself contains seven absolutely
conserved cysteine residues coordinating two zinc atoms
and does not participate in the interaction with MSL1. It
mediates E3 ubiquitin ligase catalytic activity and inter-
estingly, shows an unusual conformation of the putative
E2 interaction surface possibly reflecting an autoinhibited
state. Previous studies have demonstrated that MSL2
interaction with the complex significantly enhances its
enzymatic activity [30]. Apart from autocatalytic activity,
MSL2 ubiquitinates MSL1, which probably results in the
buffering of MSL complex levels by proteasomal degra-
dation (Figure 1d) [31,32]. Whether MSL2 has other
substrates in Drosophila is not known and will be the
matter of future investigations.
The architecture of the MOF HAT domain
enables its function as enzymatic and
protein–protein interaction module
After recognizing and binding HAS, the MSL complex
fully assembles and spreads from these docking sites to
the rest of the X chromosome resulting in chromosome-
wide H4K16ac (Figure 1c). H4K16ac is catalysed by the
MYST-family histone acetyltransferase (HAT) MOF
[12,33,34]. In vivo, mof mutation results in a loss of
H4K16ac from MSL-target genes [35]. However, a
partial complex consisting of MSL2, MLE and to some
degree MSL1 remains at HAS, demonstrating that MOF
participates in downstream events after initial targeting of
the X chromosome and complex assembly [23,36,37].
X-ray crystallography revealed that the HAT domain of
MOF uses a catalytic glutamate residue to transfer the(Figure 3 Legend Continued) high affinity sites (HAS, red box) is distinct fo
be dynamic and intrinsically allow the formation of subcomplexes possibly r
assembly, spreading, homeostasis). Note, that some binding, for example M
compensation. In mammals, some MSL complex members, instead of high
compensation systems in Drosophila and mammals with respect to the MS
physically associate with the single male X chromosome resulting in chromo
dosage compensation is achieved by inactivation of one of the two X chrom
the MSL complex targets the regulatory region of the ncRNA Tsix (Xist antis
onset of X inactivation. Ultimately, during the process of differentiation one 
which coats the entire X chromosome in cis and triggers chromosome-wide
www.sciencedirect.com acetyl moiety from CoA to the acceptor lysine, probably
in a one-step catalytic mechanism [38]. A cysteine-rich
zinc-binding module embedded in the N-terminus of the
HAT domain is important for substrate recognition [39].
Furthermore, enzymatic activity is enhanced in the pres-
ence of MSL1 and MSL3 [5] and is modulated by the N-
terminus of MOF, which is unique to Drosophila MOF
[40]. Indeed, this property is crucial for dosage compen-
sation and spreading into gene bodies of X-linked genes,
in contrast to the autosomal binding in both Drosophila, as
well as mammalian cells, where MOF seems to be re-
stricted to promoters (Figure 3b) [41].
The MOF HAT domain, apart from its enzymatic func-
tion, is also responsible for interaction with the core MSL
complex. The interaction interface is formed between the
MOF HAT domain and an alpha helix in the C-terminal
PEHE domain of MSL1 and involves multiple hydrogen
bonds and salt-bridges [38]. The MSL1 residues respon-
sible for these contacts are highly conserved, and inter-
estingly, they are also found in the PEHE domain of the
NSL complex member NSL1. This common mode of
interaction explains, why association of MOF with the
MSL and the NSL complexes is mutually exclusive [17]
and suggests, that through such interactions, MOF might
be associated with complexes other than MSL and NSL
complexes. As such, MOF might acetylate many more
proteins than previously anticipated.
Accordingly, MOF binds to autosomal gene promoters in
both male and female cells independently of the MSL
complex [35] and is the major HAT in both sexes [40].
Furthermore, it has been demonstrated that mammalian
MOF acetylates a number of substrates other than the H4
tail, MSL3 [29] and p53 in the context of the NSL
complex in mammalian cells [42].
MSL1 forms the dimeric ‘heart’ of the MSL
complex
MSL1 serves as an integral scaffold protein of the MSL
complex and is responsible for the formation of the MSL
octamer (Figure 3a). Its N-terminal coiled-coil dimer
mediates interaction with MSL2 [30]. The C-terminal
PEHE domains interact with MOF and MSL3 [38].
Between the N-terminal coiled-coiled and the C-terminal
PEHE domains, MSL1 contains a large stretch of puta-
tively unstructured amino acids (152–885). Indeed,r the individual members. This suggests that complex assembly might
eflecting the different stages of dosage compensation (targeting,
SL1 association with promoters, is also independent of dosage
 affinity sites, bind to enhancers (red box). (c) Comparison of dosage
L complex. In flies, the MSL complex and its integral ncRNA roX,
some-wide transcriptional upregulation by H4K16ac. In mammals,
osomes during female development. In mouse embryonic stem cells,
ense gene), which plays a central role in regulating levels of Xist at the
of the two Xist alleles becomes hyperactivated producing a ncRNA,
 silencing.
Current Opinion in Genetics & Development 2015, 31:1–11
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associates with promoters independently of the other
MSL complex members and/or a functional dosage com-
pensation pathway [30]. Whether the unstructured ami-
no acids and/or novel interaction partners are involved in
this binding and whether promoter association is required
for a more specific aspect of transcription regulation
remains elusive till date.
MSL3 is an adaptor protein bridging multiple
chromatin interactions
MSL3 contains two adaptor modules: the N-terminal
chromodomain (CD) and the C-terminal MRG domain.
Earlier data indicated that the CD is involved in
H3K36me3 recognition [43,44,45]. H3K36me3 chromatin
is preferentially found towards the 30 end of actively
transcribed genes and its reduction results in a X-specific
depletion of H4K16ac [46]. These data are consistent
with a model, in which the MSL complex through the
MSL3 CD-H3K36me3 interactions spreads on actively
transcribed, X-linked genes independently of the actual
gene sequence (Figure 1c). However, the above model
was brought into question as the structural analyses of the
MSL3 CD revealed an unusual polar surface, which
surprisingly makes up a ternary complex together with
DNA and H4K20 monomethylated histone tails [47,48].
Such a binding does not occur, if H4 is acetylated at K16.
How H4K20me, a mark that has been involved in DNA
damage, DNA replication and higher order chromatin
architecture, relates to dosage compensation in vivo is
currently an unsolved question. Again, it is possible that
MSL3 and its CD function outside the dosage compen-
sation pathway and in this context, H4K20 monomethy-
lation might be important.
The MRG domain of MSL3 is responsible for interaction
with MSL1 and is required to stimulate HAT activity of
MOF [4]. The MRG-mediated interaction between
MSL1 and MSL3 occurs via highly conserved phenylala-
nine residues of MSL1, which insert into several hydro-
phobic pockets of MSL3 [38]. Point mutations of these
residues result in dissociation of MSL3 from the MSL
complex and, consequently, in compromised dosage com-
pensation. How the MRG domain stimulates HAT activ-
ity of MOF is unknown. Indeed, the widespread roles of
MRG domain proteins, for example in RNA splicing [49],
suggest that the regulatory potential of MSL3 and its
MRG domain has not been fully elucidated, yet.
Nucleic acid-binding domains within the MSL
complex
Apart from the DNA-binding MSL3 CD (see above), the
core MSL complex contains two additional nucleic acid
binding domains (Figure 2). Firstly, the MOF chromo-
barrel domain is an RNA binding module [50]. Originally
considered a regular CD, later structural studies revealed
that it adopts a beta-barrel structure that is distinct fromCurrent Opinion in Genetics & Development 2015, 31:1–11 the classical CD [51]. Mutations of residues essential for
RNA binding (Tyr416 and Trp426) result in the complete
absence of male progeny. Biochemical assays revealed,
that the main function of the chromobarrel domain is to
control enzymatic activity of MOF [40].
Secondly, the MSL2 CXC domain is a nucleic acid
binding module and this plays a critical role in MSL
complex targeting to the X chromosome (Figure 1a). The
CXC domain is required, but not sufficient for MSL2
binding to DNA [22]. The solution structure of the CXC
domain has been recently determined by nuclear mag-
netic resonance (NMR) [52]. It contains a cluster of nine
strictly conserved cysteine residues, which coordinate
three zinc ions. This suggests that the domain has main-
tained DNA binding properties throughout evolution.
Tethering experiments, however, revealed, that in Dro-
sophila, MSL2 requires a co-factor to specifically recog-
nize HAS sequences on the X chromosome and initiate
dosage compensation. The recently identified protein
CLAMP might provide such a link. However, since
CLAMP is bound throughout the genome, its exact
contribution towards dosage compensation requires fur-
ther work [24].
roX RNAs contain hotspots for MSL complex
assembly
The identification of the non-coding RNAs (ncRNAs)
Xist and roX1/2 involved in dosage compensation in
mammals and Drosophila, respectively, have pioneered
a whole field working on chromatin-associated ncRNA
activities [53]. The two functionally redundant ncRNAs
roX1 and roX2 are integral components of the MSL
complex in Drosophila [6,36,50,54,55] (Figure 3). It is
fascinating that the roX1 and roX2 genes itself are
encoded on the X and contain a HAS, suggesting that
they provide unique entry sites for the MSL complex.
Indeed, MSL complex assembly will only be efficient, if
it occurs in association with the X chromosome [19].
Incorporation of roX1/2 into the MSL complex is cata-
lysed by the RNA helicase MLE and involves transient
RNA-mediated interactions with the core MSL complex
(Figure 1). Chromatin isolation by RNA purification
(ChIRP) showed, that roX2 associates with male X-linked
gene bodies and peaks at HAS, reflecting the pattern of the
core MSL complex and in particular MSL2 [56,57]. The
interplay between roX1/2 and MLE has been recently
explored in greater detail [57–59]. In vivo, individual-
nucleotide resolution UV crosslinking and immunopre-
cipitation (iCLIP) analysis revealed that MLE and MSL2
bind distinct stem-loop structures within roX1 and roX2,
which cooperate to provide functional platforms for
MSL complex assembly and spreading. Interestingly,
MLE remodels these stem-loop structures and thereby,
integrates roX1/2 into the MSL complex. Within thewww.sciencedirect.com
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to MSL2, as both proteins bind to the same roX1/2 regions
forming double-stranded RNA domains. Indeed, associa-
tion of MLE with both the complex as well as with roX1/2
seems to be transient and requires co-factors such as UNR
[60]. In this context, it is interesting to note, that MLE has
a role in splicing of the para RNA, a gene encoding a
sodium channel [61]. This reinforces the notion, that
many of the MSL complex members might play vital roles
outside the core complex.
Transcription regulation by the MSL complex
and H4K16ac
The ultimate outcome of the MSL complex action on the
male X chromosome is upregulated transcription, indepen-
dently of the actual gene sequence and length. MSL-
mediated H4K16ac might inhibit chromatin compaction
directly [62] or influence nucleosome remodelling and
spacing [63], for example in the context of trans-tail histone
modification patterns [64,65]. Which stage of the RNA
Polymerase II (RNA Pol II) transcription cycle (initiation,
pause-release, elongation or termination) is affected during
dosage compensation has been extensively studied over
the past years. Firstly, elevated H4K16ac might enhance
accessibility at the promoter, where transcription factor
binding might occur more frequently [66]. In agreement
with this model, RNA Pol II is significantly enriched at
male X-linked promoters compared to autosomes or
females [15]. On the other hand, GRO-seq experiments
[67] mapping nascent RNA production in male tissue
culture cells showed that transcriptional elongation
appears to be enhanced on X-linked versus autosomal
genes [16]. Furthermore, direct nascent RNA sequenc-
ing (DnRS), a method that captures the actual position of
RNA Pol II at steady-state, showed increasing Pol II along
the gene body towards the 30 end of the X-linked genes in
comparison to autosomes in male S2 cells[68]. Indeed,
H4K16ac is preferentially enriched on gene bodies of
active X-linked genes [37]. Taken together, the MSL
complex most likely not only facilitates early promoter
events such as Pol II recruitment and pause release but also
facilitates RNA Pol II processivity and could also ensure
efficient termination [69] of X-linked genes.
Importantly, all the methods used to date capture an
average over a population of events, involve extensive
sample preparation and lack temporal resolution. We
therefore envision that single cell and kinetic analyses will
finally allow dissecting, at which steps the MSL complex
and H4K16ac globally affect the transcription machinery
on the male X chromosome. Such studies should aim at
visualizing individual rounds of transcription in a time-
resolved manner rather than looking at averages of cells.
MSL complex function in mammals
Despite the fact that dosage compensation in mammalian
cells is fundamentally different compared to Drosophilawww.sciencedirect.com [70], at least the core MSL complex consisting of MSL1,
2, 3 and MOF is conserved in mammalian species
(Figures 2 and 3) [71,72]. This provides a unique oppor-
tunity to study the MSL complex independently of the
dosage compensation system. Indeed, two important
regulators of dosage compensation, an RNA helicase
homologous to MLE or a ncRNA component such as
roX have not been identified in the mammalian complex,
so far [72,73]. Interestingly, since MLE and MSL2 bind
to relatively small stem loop structures within roX RNAs
in vivo, it is possible that if the orthologues interact with
ncRNAs, the overall size of such ncRNAs could also be
variable.
Recently, H4K16ac and the core mammalian MSL com-
plex have been studied genome-wide in mammalian cells
and revealed a remarkable functional complexity. Firstly,
the MSL complex seems to co-operate with the NSL
complex in regulating housekeeping genes through pro-
moter association in a cell-type invariant manner [41,74].
Indeed, association with the NSL complex seems to be
the dominant function of MOF, at least on a genome-
wide level. Interestingly, a very small fraction of genes
showed exclusive enrichment for the MSL complex,
including the regulatory region of Tsix, a non-coding
transcript that is critically involved in orchestrating X
inactivation in rodents [75]. Therefore, the MSL complex
is also required for efficient Tsix expression and, in
consequence, determination of transcription and accumu-
lation of Xist in differentiating female murine embryonic
stem cells. Remarkably, there is also evidence for a
function of MOF and/or the MSL complex in upregulat-
ing the active X chromosome, which is currently a matter
of active investigation [76–79]. Certainly, additional stud-
ies will be essential for clarifying the role of the MSL
complex in regulating mammalian X inactivation as well
as activation.
Interestingly, mammalian MSL complex members also
appear to bind chromatin individually, suggesting that
they might carry regulatory potential independent of the
core MSL complex. Particularly, MSL2 binds to a large
number of genomic locations independently of the MSL
complex. Secondly, MSL2 and to a certain extent also
MOF associates with tissue-specific enhancers. Because
H4K16ac has been found at enhancers, while surprisingly
not affecting chromatin accessibility, it is possible that
MOF and/or MSL2 regulate enhancers in a completely
novel manner than appreciated from earlier studies in
Drosophila [80]. One possibility is that they might regulate
transcription of enhancer RNAs, which have been recent-
ly identified as crucial regulators of enhancer function
[81].
Conclusions
Structural, biochemical and genome-wide studies per-
formed in the recent years have shed light on the highlyCurrent Opinion in Genetics & Development 2015, 31:1–11
8 Genome architecture and expressionmodular architecture of the MSL complex, which has
evolved to function as a male-specific transcription regu-
lator on the Drosophila X-chromosome. Although these
studies advanced our understanding of the MSL complex
modules, we are currently missing the bigger picture.
How do these modules play together in the full complex?
How does the MSL complex achieve such a remarkable
precision in targeting as well as its impact on gene
expression? And how do the chromatin binding profiles
relate to biochemically defined (sub)complexes exerting
different MSL complex functions: targeting, assembly,
spreading, homeostasis? These compelling questions still
await their answer. We envision, that structural analyses
combined with studies focusing on complex dynamics
using novel single-molecule and imaging techniques
might provide important insights, which will finally help
to understand this highly complex interplay of the MSL
complex members in dosage compensation in flies.
On the other hand, the modular principle and the high
degree of MSL complex conservation suggest that many
of the members function also outside of dosage compen-
sation. This has become particularly evident in the recent
studies in mammals, revealing that we have probably only
scratched the surface in understanding the regulatory
potential of the MSL complex and its individual mem-
bers.
Indeed, we currently lack in depth proteomic studies of
the MSL complex members in other species than
Drosophila. Considering the rapid developments in ge-
nome editing technologies, it will be feasible to perform
such studies in an endogenous context and in different
cell types in the near future. This will allow us to
biochemically define individual pathways and functions,
in which the MSL complex is acting. Looking at the MSL
complex in a different light, it will be equally important to
study MSL complex isoforms. Differential isoform ex-
pression is prevalent in mammalian systems, and in
addition to different interaction partners, isoforms might
explain the multiple facets of the MSL complex.
Furthermore, it is important to note that the full reper-
toire of substrates of the two enzymes, MOF and MSL2,
is probably not fully elucidated, yet. For example, MSL2
ubiquitinates p53 and thereby promotes p53 translocation
to the cytoplasm [82]. In addition, MOF acetylates p53,
which might explain its role in DNA damage repair [83].
Identification of novel MOF and MSL2 substrates, in the
context of the MSL complex and other complexes, will
therefore be important jigsaw pieces in understanding
MSL complex function.
Lastly, future studies will have to address the mechanism
of MSL complex-mediated transcription regulation. For
example, human MSL1/2 has been involved in H2BK34
mono-ubiquitination, which results in crosstalk with otherCurrent Opinion in Genetics & Development 2015, 31:1–11 histone modifications and enhanced processivity of RNA
Pol II via PAF1 and pTEFb [84,85]. How the MSL
complex affects the transcription machinery directly,
both during dosage compensation and in other processes,
is an outstanding question in the field. Altogether, these
studies will help to understand the multiple facets of the
MSL proteins, which function in many essential process-
es, dosage compensation and beyond.
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